New ACC/AHA Guideline for Primary Prevention of CVD Presented at ACC 2019
The American College of Cardiology and American Heart Association have released a new evidence-based guideline detailing the primary prevention of cardiovascular disease.
General Cardiology
‘Potentially Concerning’ Signal Identified in Long-Term Follow-up Data Involving Paclitaxel-Coated Products
Paclitaxel-coated devices were associated with an approximately 50% increased risk of death when compared with control devices.
AHA, Joint Commission Offer New Hospital Certifications for Comprehensive ACS Care
The certifications will establish comprehensive, evidence-based standards for cardiac and stroke care.
AHA: 2019 Update on Heart Disease and Stroke Statistics
Data include statistics on tobacco use, cardiovascular health, physical activity, nutrition, blood pressure, and cholesterol, among others.
AHA Issues Scientific Statement on Accurate Blood Pressure Readings
The American Heart Association has updated its scientific statement on blood pressure readings.
Greater Income Inequality Is Associated With Worse Heart Failure Outcomes
The investigators of this study sought to examine the impact of income inequality on heart failure outcomes among different countries.
Societies Release Updated Guidelines for the Management of Atrial Fibrillation
In order to revise the guidelines, the Task Force reviewed clinical trials presented at the annual scientific meetings of the ACC, AHA, HRS, and European Society of Cardiology in addition to other peer-reviewed, published data.
Income Drops and Volatility Linked With Cardiovascular Events and Mortality
The risk for cardiovascular disease and all-cause mortality have been correlated with income drops and volatility.
Device Approved to Treat Premature Infants With Common Heart Defect
The pea-sized device is a self-expanding wire mesh that is inserted through an incision in the leg and guided through vessels to the heart, where it is placed to seal the opening.
FDA to Review Tafamidis for Treatment of Transthyretin Amyloid Cardiomyopathy
Tafamidis is an oral small molecule candidate that selectively binds at specific sites on the transthyretin tetramer to prevent destabilization of the transthyretin transport protein and formation of amyloid that causes ATTR-CM.
Next post in Medicine
